Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today announced the appointment of Steve Levine ...

The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

Advarra conducted a survey of sites, sponsors, and CROs that revealed three biggest barriers to stakeholder collaboration: communications, staffing, and technology.

ON KETV NEWSWATCH SEVEN AT SIX. THE MAN CONVICTED OF KILLING A PERU STATE COLLEGE STUDENT ASKED A JUDGE TO GRANT HIM A NEW TRIAL. LAWYERS FOR JOSHUA KEADLE FILED THAT MOTION IN GAGE COUNTY COURT.

The approximately $24 million project will benefit the school's clinical research infrastructure and support research for conditions like cancer, cardiac disease and strokes. UofL ...

CHICAGO (WLS) -- The corruption trial for former Illinois House Speaker ... Duray noted that there was no mention in any of the documents that subcontractors were getting paid in those two contracts.

In December, Dr. Subbiah was named chief clinical effectiveness officer at ... our entire community care model to prevent avoidable hospital visits." 2 major challenges Like most systems, the ...

CHICAGO (WLS) -- The corruption trial for former Illinois House Speaker Michael Madigan continues. Madigan had been indicted on federal racketeering and bribery charges as a part of what federal ...

Sanofi is banking on the totality of data from the three phase 3 trials ... it files the drug for approval in MS. The drug is one of several oral BTK drugs that have been in clinical development ...

Our research takes place in a highly multidisciplinary environment, unique in placing high-quality fundamental and applied science at the interface of a busy clinical service with an academic mix of ...

What specific group of postmenopausal women are the focus of most fracture-prevention strategies? Currently, most fracture-prevention strategies focus on persons at highest risk for fracture ...

Montpellier-based Sensorion has applied to the UK's Medicines & Healthcare products Regulatory Agency (MHRA) to start a phase 1/2 clinical of ... in its phase 1/2 CHORD trial of DB-OTO.